Immunotherapy of inflammatory sinus and ear disease

Details Immunotherapy of inflammatory sinus and ear disease Immunotherapy of inflammatory sinus and ear disease

1996-07-10

2000-02-22

Bawa, Raj

Drug, bio-affecting and body treating compositions

Effervescent or pressurized fluid containing

Organic pressurized fluid

514 2, 514871, 514887, A61K 912

Patent

active

060277122

ABSTRACT:
A composition and method useful for treating commonly occurring inflammatory disease of the nose, ears and sinuses are described. Interleukin-1 (IL-1), a naturally occuring and generally non-toxic composition, is one of the key mediators of the biomolecular inflammatory reaction. IL-1 antagonists have been found in the human body. The IL-1 antagonists are thought to function as natural modulators of the inflammatory response. The present invention employs IL-1 receptor antagonist to block the runaway inflammatory cascade associated with inflammatory disease of the paranasal sinuses and middle ear. The composition and method prevents the long term complications of this disease and reduces the need for costly surgical intervention which is currently performed in more advanced cases.

REFERENCES:
patent: 5075222 (1991-12-01), Hannum et al.
Evans, C. H., and P. D. Robbins. (1994). Receptor, vol. 4, p. 9-15.

Affiliated with

Also associated with

Rating

Immunotherapy of inflammatory sinus and ear disease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immunotherapy of inflammatory sinus and ear disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunotherapy of inflammatory sinus and ear disease will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-518036